Search Results 1-10 of 28496 for ������������������������������������������������r���:za33���

  1. Rizatriptan (Oral Route) Description and Brand Names - Mayo Clinic

    Rizatriptan works in the brain to relieve the pain from migraine headaches. It belongs to the group of medicines called triptans.

  2. Overview - Infection and Immunity: Raymund R. Razonable - Mayo Clinic Research

    The Infection and Immunity Lab of Raymund R. Razonable, M.D., at Mayo Clinic studies COVID-19 and transplant-related infections such as cytomegalovirus ...

  3. Publications - R John Presutti, D.O. - Mayo Clinic

    Presutti RJ, Pujalte GGA, Woodruff A, Agarwal A, Robinson CN, Reese RL, Helmi H, Wight JT. Do physicians know when to refer patients for genetic testing?

  4. Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™ - Mayo Clinic

    Subjects will be randomized 1:1 to R-CHOP plus enzastaurin or R CHOP (plus placebo during induction). All subjects will receive up to 6 cycles (3 weeks per ...

  5. Matthew R. Callstrom, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    SUMMARY. Matthew R. Callstrom, M.D., Ph.D., is a consultant in the Division of Diagnostic Radiology at Mayo Clinic and a professor of radiology at Mayo ...

  6. (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive - Mayo Clinic

    (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive.

  7. Raymund R. Razonable, M.D. - Mayo Clinic Faculty Profiles

    Raymund R. Razonable, M.D., is an infectious disease specialist at Mayo Clinic who studies viral infections, cytomegalovirus and infections related to ...

  8. A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

    This Phase 2, two-arm, open-label study is designed to evaluate the safety, clinical activity, predictive biomarkers and pharmacokinetics/ pharmacodynamics of ...

  9. R-3750 in Patients With Mild to Moderate Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to determine safety and tolerability of orally delivered R-3750 in mild to moderate patients with ulcerative colitis. Participation ...

  10. Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients - Mayo Clinic

    The purpose of this study is to compare the effectiveness and safety of the humanized monoclonal anti CD19 antibody tafasitamab plus lenalidomide in addition to ...